recruited 128 advanced oropharyngeal cancer (OPC) patients treated with chemoradiation and developed a nomogram combined with hemoglobin (Hb), SII, and SIRI for predicting disease-specific survival (DSS) (35). Here, GSTM1 is linked to oropharynx cancer.